Found 0 matching trials
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) PHASE2 The goal of this clinical research study is to compare how 2 different drug...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia PHASE1 This phase I/II trial studies the side effects and best dose of venetoclax ...
Show More Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Learn More & Join Trial
Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations PHASE1 This phase I trial studies the side effects and best dose of pacritinib whe...
Show More Location
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center
Learn More & Join Trial
Platelet Response During the Second Cycle of Decitabine Can Predict Response and Survival for Myelodysplastic Syndrome N/A To assess the efficacy of decitabine and identify predictors for response t...
Show More Location
Division of Hematology Oncology, Samsung Medical Center
Learn More & Join Trial
PRO#0118: Decitabine Plus Mini Flu-Bu PHASE1 This is a single institution study of combining decitabine with fludarabine...
Show More Location
Hackensack University Medical Center - John Theurer Cancer Center
Learn More & Join Trial
Prospective Study of Patients With Thrombocytopenia Following HSCT PHASE3 Isolated thrombocytopenia is a common and severe complication of HSCT, whic...
Show More Location
The First affiliated Hospital of SooChow University
Learn More & Join Trial
Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome PHASE2 The purpose of this study is to provide decitabine to patients with Acute M...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia PHASE3 The primary objective of this study is to demonstrate the efficacy of Iomab...
Show More Status
Active Not Recruiting
Location
Banner MD Anderson Cancer Center
Learn More & Join Trial
FHD-286 as Monotherapy or Combination Therapy in Subjects With Advanced Hematologic Malignancies PHASE1 This Phase 1, multicenter, open-label, dose escalation study is designed to...
Show More Status
Active Not Recruiting
Location
City of Hope National Medical Center
Learn More & Join Trial
Comparison of the Efficacy and Safety of Venetoclax in Combination With 3 Days Decitabine (DEC3-VEN) vs. Venetoclax in Combination With Azacitidine (VIALE-A) in the Treatment of Elderly Patients or Unfit, New-diagnosis Acute Myeloid Leukemia Patients PHASE3 Combining the results of previous studies and based on the clinical practic...
Show More Location
The Second Affiliated Hospital of Kunming Medical University.
Learn More & Join Trial